Phase II study of neoadjuvant hormonal therapy guided by interval Ki67 testing in hormonal receptor-positive, HER2-negative breast cancer.
عنوان الدراسة
Phase II study of neoadjuvant hormonal therapy guided by interval Ki67 testing in hormonal receptor-positive, HER2-negative breast cancer.
داعم الدراسة
King Abdullah Medical City (Makkah)
دواء الدراسة
Letrozole (Femaplex)
رقم بروتوكول الدراسة
20-718
حالة الدراسة
Ongoing
موقع الدراسة
King Abdullah Medical City (Makkah)
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.